Cutaneous T-cell lymphoma is a malignancy of functional, tissue-specif
ic T cells. Many characteristics of the disease can be explained by vi
rtue of the ability of the malignant cell population to actively parti
cipate in the host's immunologic network. Various aspects of this dyna
mic interplay between malignant and benign T cells are discussed, incl
uding impact on diagnosis, staging, and therapy.